GNLX PEER ANALYSIS

Genelux Corporation Common Stock — metric-by-metric comparison with peers and the industry median

GNLXGenelux Corporation Common Stock

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

GNLXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	GNLX	RTALB	MSB	TLX	Ind. Median
P/E	—	4.89	—	—	17.81
P/B	4.28	0.61●	—	6.56	3.49
EV/EBITDA	—	74.61●	—	123.31	14.92
P/S	12,268.75	6.67	31.91	3.34●	10.89

Financial Health
Metric	GNLX	RTALB	MSB	TLX	Ind. Median
Current Ratio	3.68●	1.21	—	1.43	5.90
Debt/Equity	10.9%	1.2%●	—	112.3%	10.9%
NetDebt/EBITDA	0.74●	0.90	—	13.13	1.15

Profitability
Metric	GNLX	RTALB	MSB	TLX	Ind. Median
Net Margin	-397,225.0%	136.3%●	-115.3%	-0.9%	-125.7%
ROE	-120.4%	15.1%●	-11.3%	-1.8%	-47.5%
ROA	-89.1%	13.1%●	-8.6%	-0.7%	-35.8%
EBITDA Margin	-400,537.5%	9.0%●	-76.6%	3.0%	-105.8%

Growth + Dividend
Metric	GNLX	RTALB	MSB	TLX	Ind. Median
Rev. Growth	-99.4%	24.0%	410.4%●	56.3%	5.1%
NI Growth	—	134.0%	—	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	GNLX	ACET	BMEA	SEER	RLYB	ALXO	Ind. Median
P/E	—	—	—	—	—	—	17.81
P/B	4.28	0.70	5.33	0.51●	1.78	0.79	3.49
EV/EBITDA	—	—	—	—	—	—	14.92
P/S	12,268.75	—	—	8.35●	104.22	—	10.89

Financial Health
Metric	GNLX	ACET	BMEA	SEER	RLYB	ALXO	Ind. Median
Current Ratio	3.68	7.65	4.98	17.73●	12.92	7.21	5.90
Debt/Equity	10.9%	9.9%	6.6%	9.5%	0.3%●	3.4%	10.9%
NetDebt/EBITDA	0.74●	1.20	0.94	2.10	1.66	1.56	1.15

Profitability
Metric	GNLX	ACET	BMEA	SEER	RLYB	ALXO	Ind. Median
Net Margin	-397,225.0%	—	—	-480.2%●	-911.1%	—	-125.7%
ROE	-120.4%	-72.2%	-189.4%	-25.5%	-15.0%●	-74.2%	-47.5%
ROA	-89.1%	-60.4%	-88.6%	-22.8%	-13.9%●	-59.4%	-35.8%
EBITDA Margin	-400,537.5%	—	—	-466.5%●	-3,270.4%	—	-105.8%

Growth + Dividend
Metric	GNLX	ACET	BMEA	SEER	RLYB	ALXO	Ind. Median
Rev. Growth	-99.4%	-100.0%	-100.0%	-3.2%	1.2%●	-100.0%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on GNLX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.